Pfg Investments, LLC Dexcom Inc Transaction History

Pfg Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$110.31 - $140.45 $319,126 - $406,321	-2,893 Reduced 54.45%	2,420 $274 Million
Q1 2024 Apr 22, 2024	BUY	$114.22 - $140.1 $321,300 - $394,101	2,813 Added 112.52%	5,313 $737 Million
Q4 2023 Jan 17, 2024	SELL	$75.49 - $124.16 $30,346 - $49,912	-402 Reduced 13.85%	2,500 $310 Million
Q3 2023 Nov 06, 2023	BUY	$86.06 - $137.93 $249,746 - $400,272	2,902 New	2,902 $271 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pfg Investments, LLC with notifications on news.